Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanara MedTech (SMTI) Goodwill (2022 - 2025)

Historic Goodwill for Sanara MedTech (SMTI) over the last 4 years, with Q3 2025 value amounting to $3.6 million.

  • Sanara MedTech's Goodwill changed 0.0% to $3.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.6 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $3.6 million for FY2024, which is 0.0% changed from last year.
  • Latest data reveals that Sanara MedTech reported Goodwill of $3.6 million as of Q3 2025, which was down 0.0% from $3.6 million recorded in Q2 2025.
  • In the past 5 years, Sanara MedTech's Goodwill ranged from a high of $3.6 million in Q4 2022 and a low of $3.3 million during Q3 2022
  • Over the past 4 years, Sanara MedTech's median Goodwill value was $3.6 million (recorded in 2022), while the average stood at $3.6 million.
  • Within the past 5 years, the most significant YoY rise in Sanara MedTech's Goodwill was 989.3% (2023), while the steepest drop was 0.0% (2023).
  • Sanara MedTech's Goodwill (Quarter) stood at $3.6 million in 2022, then changed by 0.0% to $3.6 million in 2023, then changed by 0.0% to $3.6 million in 2024, then changed by 0.0% to $3.6 million in 2025.
  • Its last three reported values are $3.6 million in Q3 2025, $3.6 million for Q2 2025, and $3.6 million during Q1 2025.